Benlysta press kit

The information on this page is intended for healthcare journalists and analysts/investors.

Press release

  • March 09, 2011 GlaxoSmithKline and Human Genome Sciences announce FDA approval of Benlysta® (belimumab) for the treatment of systemic lupus erythematosus

Background information

Product photos

Benlysta product shot
Benlysta product shot

External information